Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era.
Saved in:
| Title: | Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era. |
|---|---|
| Authors: | Major A; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Dueck AC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA., Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, MN, USA. |
| Source: | The Lancet. Haematology [Lancet Haematol] 2025 Jun; Vol. 12 (6), pp. e451-e462. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2352-3026 |
|---|---|
| DOI: | 10.1016/S2352-3026(25)00035-3 |
